Data di Pubblicazione:
2021
Citazione:
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study / Felker, G Michael; Mcmurray, John J V; Cleland, John G; O'Connor, Christopher M; Teerlink, John R; Voors, Adriaan A; Belohlavek, Jan; Böhm, Michael; Borentain, Maria; Bueno, Hector; Cole, Robert T; Desouza, Mary M; Ezekowitz, Justin A; Filippatos, Gerasimos; Lang, Ninian N; Kessler, Paul D; Martinez, Felipe A; Mebazaa, Alex; Metra, Marco; Mosterd, Arend; Pang, Peter S; Ponikowski, Piotr; Sato, Naoki; Seiffert, Dietmar; Ye, June. - In: JACC. HEART FAILURE. - ISSN 2213-1779. - (2021). [10.1016/j.jchf.2020.10.012]
Abstract:
The primary objective was to identify well-tolerated doses of cimlanod in patients with acute heart failure (AHF). Secondary objectives were to identify signals of efficacy, including biomarkers, symptoms, and clinical events.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
acute heart failure; clinical trials; drug therapy; nitroxyl
Elenco autori:
Felker, G Michael; Mcmurray, John J V; Cleland, John G; O'Connor, Christopher M; Teerlink, John R; Voors, Adriaan A; Belohlavek, Jan; Böhm, Michael; Borentain, Maria; Bueno, Hector; Cole, Robert T; Desouza, Mary M; Ezekowitz, Justin A; Filippatos, Gerasimos; Lang, Ninian N; Kessler, Paul D; Martinez, Felipe A; Mebazaa, Alex; Metra, Marco; Mosterd, Arend; Pang, Peter S; Ponikowski, Piotr; Sato, Naoki; Seiffert, Dietmar; Ye, June
Link alla scheda completa:
Pubblicato in: